Macrophage Pharma (AgeTech UK) Biomed
Reprogramming macrophages to tackle diseases, e.g. oncology and inflammation (inflammosome inhibitor in a pipeline).
Technology:
AgeTech Companies
Industry:
UK AgeTech 2020
Headquarters:
United Kingdom
Founded Date:
N/A
Employees Number:
N/A
Funding Status:
N/A
Register and Claim Ownership